184 related articles for article (PubMed ID: 22722500)
1. Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
Lee ST; Ryu S; Kim SR; Kim MJ; Kim S; Kim JW; Lee SY; Hong KS
J Clin Psychopharmacol; 2012 Aug; 32(4):441-8. PubMed ID: 22722500
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
[TBL] [Abstract][Full Text] [Related]
3. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
[TBL] [Abstract][Full Text] [Related]
4. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS
Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
[TBL] [Abstract][Full Text] [Related]
6. Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine.
Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
Per Med; 2022 May; 19(3):181-192. PubMed ID: 35259926
[TBL] [Abstract][Full Text] [Related]
7. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.
Carrillo JA; Herraiz AG; Ramos SI; Benítez J
J Clin Psychopharmacol; 1998 Aug; 18(4):311-6. PubMed ID: 9690697
[TBL] [Abstract][Full Text] [Related]
8. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
9. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
Albitar O; Harun SN; Sheikh Ghadzi SM
CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms potentially related to the pharmacokinetics of clozapine: a systematic review.
Krivoy A; Gaughran F; Weizman A; Breen G; MacCabe JH
Int Clin Psychopharmacol; 2016 Jul; 31(4):179-84. PubMed ID: 25563806
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients.
M N; Patil AN; Pattanaik S; Kaur A; Banerjee D; Grover S
Asian J Psychiatr; 2020 Feb; 48():101918. PubMed ID: 31896438
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
Sriretnakumar V; Huang E; Müller DJ
Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
[TBL] [Abstract][Full Text] [Related]
13. The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone.
Jovanović N; Božina N; Lovrić M; Medved V; Jakovljević M; Peleš AM
Eur J Clin Pharmacol; 2010 Nov; 66(11):1109-17. PubMed ID: 20563569
[TBL] [Abstract][Full Text] [Related]
14. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL
J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379
[TBL] [Abstract][Full Text] [Related]
15. Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone.
Liu X; Sun H; Zhang Y; Sun Y; Wang W; Xu L; Liu W
Toxicol Appl Pharmacol; 2021 Jul; 422():115560. PubMed ID: 33957192
[TBL] [Abstract][Full Text] [Related]
16. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
[TBL] [Abstract][Full Text] [Related]
17. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
Ganoci L; Trkulja V; Živković M; Božina T; Šagud M; Lovrić M; Božina N
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110042. PubMed ID: 32682874
[TBL] [Abstract][Full Text] [Related]
18. Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables.
Mansour K; Fredj NB; Ammar H; Romdhane HB; Mhalla A; Chaabane A; Chadli Z; Aouam K
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):805-817. PubMed ID: 38599832
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
